1st Circ. To Size Up Antitrust Shield In Enoxaparin Row
The First Circuit on Thursday will consider whether a lower court correctly held that drugmaker Momenta was immune from a suit from rival Amphastar over a generic anticoagulant in a case...To view the full article, register now.
Already a subscriber? Click here to view full article